tiprankstipranks
AN2 Therapeutics gets continuation grant to discover novel boron based therapies
PremiumThe FlyAN2 Therapeutics gets continuation grant to discover novel boron based therapies
4M ago
AN2 Therapeutics adopts limited duration stockholder rights plan
Premium
The Fly
AN2 Therapeutics adopts limited duration stockholder rights plan
6M ago
AN2 Therapeutics reports Q2 EPS (48c), consensus (59c)
Premium
The Fly
AN2 Therapeutics reports Q2 EPS (48c), consensus (59c)
6M ago
AN2 Therapeutics price target lowered to $3 from $6 at JMP Securities
PremiumThe FlyAN2 Therapeutics price target lowered to $3 from $6 at JMP Securities
7M ago
AN2 Therapeutics Announces Major Restructuring and Cost-Cutting Measures
Premium
Company Announcements
AN2 Therapeutics Announces Major Restructuring and Cost-Cutting Measures
7M ago
Intuit initiated, Charter downgraded: Wall Street’s top analyst calls
Premium
The Fly
Intuit initiated, Charter downgraded: Wall Street’s top analyst calls
8M ago
AN2 Therapeutics reports Q4 EPS (57c), consensus (75c)
PremiumThe FlyAN2 Therapeutics reports Q4 EPS (57c), consensus (75c)
11M ago
ANTX Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
ANTX Earnings this Week: How Will it Perform?
11M ago
Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
Premium
The Fly
Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
12M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100